Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

NCT00580333 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cisplatin
DRUG: bevacizumab
DRUG: doxorubicin
DRUG: cyclophosphamide
DRUG: paclitaxel

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]